[1]
“A Comparative Study of Regulatory Guidelines, Digital Pharmacovigilance, and Software as a Medical Device across High- and Low-to-Middle-Income Countries: Research Article”, JOPIR, vol. 4, no. 2, pp. 304–319, Apr. 2026, doi: 10.69613/mdb50d20.